Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Kabra Drugs has informed that the trading window shall remain closed from October 1, 2023 till 48 hours after announcement of the Unaudited Financial Results for the Quarter Ended 30th September, 2023. The date of Board Meeting will be informed in due course.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.20 |
| Dr. Reddys Lab | 1224.05 |
| Cipla | 1213.90 |
| Zydus Lifesciences | 925.80 |
| Lupin | 2321.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: